JVP was founded in 1993 by Dr. Erel Margalit, is an internationally renowned VC fund. JVP has raised $1.5 billion to date, and has been listed numerous times by Preqin, and other rankings, as one of the top-six consistently performing VC firms worldwide.
JVP has built over 150 companies, leveraging a broad network of partners and market expertise to help companies become global market leaders.
Among the pioneering firms of the Israeli VC industry, JVP has been instrumental in building some of the world’s largest companies to emerge, facilitating numerous IPOs on NASDAQ, including CyberArk Software (NASDAQ: CYBR, $4.7 billion mkt. cap.), QLIK Technologies (NASDAQ: QLIK, then $4 billion mkt. cap.) and Cogent Communications (NASDAQ: CCOI, $3 billion mkt. cap.) as well as many large industry sales.
JVP invests in early-stage start-ups and later-stage companies in the areas of artificial intelligence, big data, cyber-security, digital health, enterprise software, insuretech, fintech, and more.
Over the past decade JVP has spearheaded the creation of international Centers of Excellence, including the AI and Media center in Jerusalem, the Cyber center in Beer Sheva, the Foodtech and Agritech center in the Galilee, the International Cyber and FinTech center in NYC, in partnership with NYC/EDC and the leading universities of the city. Recently JVP has decided to open a newly emerging center in the UAE that will be a new chapter for Israeli technologies to engage with the region.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal and Metabolism, and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
In 2019, AstraZeneca launched BeyondBio, its investment program in research and innovation in Israel. BeyondBio is part of a global network of innovation hubs and runs several projects in Israel with multiple partners. AstraZeneca opened its Israeli office in 2008.
Dr. Erel Margalit, Founder and Chairman of Jerusalem Venture Partners (JVP), one of the top six venture capital firms (VCs) worldwide. Recognized as one of the architects of the Start-up Nation, Dr. Margalit is a world-renowned business and social entrepreneur who developed a private public partnership (PPP) model to create tech-driven ecosystems in Jerusalem and Beer Sheva. Israel Initiative 2020 is a leading Israeli NGO (ii2020) was established by Dr. Erel Margalit in 2013, based on his socio-economic vision to advance higher quality employment within these regions. Recognizing the huge opportunity for growth, Margalit Startup City Community is working to bring the innovation revolution to these regions, reducing the gaps and promoting prosperity throughout society creating seven regions of excellence from north to south.
Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services—all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 537,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities.
AWS is the trusted technology partner to the global healthcare and life sciences industry. For over 14 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. Trusted by thousands of healthcare and life sciences customers around the world—including the fastest-growing startups, the largest enterprises, and the leading government agencies. AWS offers secure and compliant solutions to keep protected health information (PHI) private enabling the highly regulated healthcare and life sciences industry to increase the pace of innovation, unlock the potential of data, improve clinical and operational efficiency, and personalize the healthcare journey, improving the healthcare experience and ultimately patient outcomes. To learn more, visit aws.amazon.com/health.
Shaare Zedek Scientific Ltd. (Mada’it) is a subsidiary of Shaare Zedek Medical Center, Jerusalem’s fastest growing major medical center which treats over 800,000 medical cases annually. Unique in our status as a private/public medical provider, Shaare Zedek provides a specific advantage in offering all the benefits and access of a major public healthcare institution. Our strength is in converting initial research initiatives into novel medical treatments by leveraging our hospital’s abilities, facilities, patients and expertise for the advancement of medical science. In multiple clinical realms, we offer our research partners unique access to clinical data, patients, materials and knowledge leading to specific scientific advantages.
Shaare Zedek Medical Center employs nearly 1000 physicians in 30 departments and 70 ambulatory units with over 1,000 patient beds. Our Emergency Medicine Department is the largest in Jerusalem and treats 150,000 patients every year. The maternity departments see over 22,000 deliveries annually, establishing Shaare Zedek as one of the world’s most active maternity hospitals.
Shaare Zedek Scientific, as a one-stop-shop, is the point of contact for companies in regards to all aspects of the interacting with the hospital, dedicated to promote an always-expanding and increasingly productive collaboration with key industry players.